Yap G S, Stevenson M M
Centre for the Study of Host Resistance, Montreal General Hospital Research Institute, Quebec, Canada.
Exp Parasitol. 1992 Nov;75(3):340-52. doi: 10.1016/0014-4894(92)90219-z.
The course of anemia and the erythropoietic response in the bone marrow, spleen, and blood were studied during Plasmodium chabaudi AS infection in resistant C57BL/6 (B6) and susceptible A/J (A) mice. Infections in B6 mice were characterized by moderate levels of both parasitemia and anemia and survival. In contrast, A mice experienced high parasitemia, severe anemia, and high mortality rates. During the period of anemia, erythropoiesis, as measured by in vivo 59Fe incorporation, was significantly more depressed in bone marrow and more increased in the spleen in resistant B6 mice. The increase in splenic 59Fe incorporation was a function of the size of the spleen. Bone marrow CFU-E were decreased to 50% of control in both strains, while splenic CFU-E were increased twofold greater in B6 mice compared to those in A mice. However, the absolute numbers of CFU-E per spleen in the two strains were not significantly different during peak parasitemia. Bone marrow BFU-E were transiently increased before peak parasitemia whereas splenic BFU-E peaked during peak parasitemia. A mice had significantly lower numbers of BFU-E per spleen on all days except at peak parasitemia. The frequency of blood-borne BFU-E and plasma erythropoietin titers was increased earlier and to a greater extent in A mice. These results suggest that an impaired amplification of late-stage splenic erythropoiesis may be an important determinant in the severity of anemia and lethality of infection with P. chabaudi AS in A mice. Moreover, these results demonstrate that the defective amplification of splenic erythropoiesis in A mice is neither caused by a defect in the mobilization of BFU-E from the bone marrow to the spleen nor caused by a defect in erythropoietin production.
在抗疟的C57BL/6(B6)小鼠和易感的A/J(A)小鼠感染查巴迪疟原虫AS期间,研究了贫血的病程以及骨髓、脾脏和血液中的红细胞生成反应。B6小鼠的感染特征为疟原虫血症、贫血和存活率均处于中等水平。相比之下,A小鼠经历了高疟原虫血症、严重贫血和高死亡率。在贫血期间,通过体内59Fe掺入量测定,抗疟的B6小鼠骨髓中的红细胞生成明显更受抑制,而脾脏中的红细胞生成则增加更多。脾脏中59Fe掺入量的增加是脾脏大小的函数。两种品系的骨髓CFU-E均降至对照的50%,而B6小鼠脾脏中的CFU-E比A小鼠增加了两倍。然而,在疟原虫血症高峰期,两种品系每脾脏CFU-E的绝对数量并无显著差异。骨髓BFU-E在疟原虫血症高峰前短暂增加,而脾脏BFU-E在疟原虫血症高峰期达到峰值。除疟原虫血症高峰期外,A小鼠在所有天数每脾脏的BFU-E数量均显著较低。A小鼠血源性BFU-E的频率和血浆促红细胞生成素滴度更早且更大程度地增加。这些结果表明,晚期脾脏红细胞生成的扩增受损可能是A小鼠感染查巴迪疟原虫AS时贫血严重程度和感染致死率的一个重要决定因素。此外,这些结果表明,A小鼠脾脏红细胞生成的缺陷扩增既不是由BFU-E从骨髓向脾脏的动员缺陷引起的,也不是由促红细胞生成素产生缺陷引起的。